The American Society of Clinical Oncology (ASCO), over 25,000 members strong, includes representatives from all areas of cancer care:... Read more »
I wrote about CYP2D6, which refers to a gene that codes for a biologic molecule involved in the breakdown of tamoxifen, about a year ago. ... Read more »
The blogwaves were buzzing recently with the news that tamoxifen (nolvadex), the once (and perhaps future) king of breast cancer prevention... Read more »
Tamoxifen (or nolvadex) is a drug commonly prescribed to prevent the recurrence of breast cancer, but a common side effect of the... Read more »
A recent study of breast cancer patients showed that about a third of women stopped taking their tamoxifen (nolvadex) before the end of the... Read more »
Source: Breastcancer.org
Tamoxifen, the generic name of Nolvadex, is the oldest and most-prescribed SERM. Tamoxifen is approved by the U.S. Food and Drug Administration (FDA)... Read more »
A new study has found that letrozole (Femara) increases survival more than tamoxifen for postmenopausal women who have undergone surgery. In the... Read more »
Scottish researchers say that many women are risking their lives by skipping doses of the breast cancer drug tamoxifen. The study found that as many... Read more »
Very few women who do not have a family history of breast cancer use Tamoxifen as a preventive medication, a new study has found. Researchers say the... Read more »
Source: Breastcancer.org
You've just finished chemotherapy and are ready to get pregnant. Then your doctor says you should start tamoxifen. Tamoxifen is a hormonal therapy... Read more »